{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:30:10Z","timestamp":1772166610846,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Anhui Provincial University Research Foundation","award":["No. 2022AH051491"],"award-info":[{"award-number":["No. 2022AH051491"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02945-1","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:21:13Z","timestamp":1759234873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The protective mechanism of taurine deoxycholic acid (TCDCA) through LPAR1 regulation in Buga syndrome"],"prefix":"10.1186","volume":"30","author":[{"given":"Zeyu","family":"Guan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoGao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erchang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"7","key":"2945_CR1","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/liv.14088","volume":"39","author":"A Zanetto","year":"2019","unstructured":"Zanetto A, Pellone M, Senzolo M. Milestones in the discovery of Budd-Chiari syndrome. Liver Int. 2019;39(7):1180\u20135.","journal-title":"Liver Int"},{"key":"2945_CR2","first-page":"1","volume":"2015","author":"W Zhang","year":"2015","unstructured":"Zhang W, Qi X, Zhang X, et al. Budd-chiari syndrome in China: a systematic analysis of epidemiological features based on the Chinese literature survey. Gastroenterol Res Pract. 2015;2015:1\u20138.","journal-title":"Gastroenterol Res Pract"},{"issue":"3","key":"2945_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S1499-3872(11)60042-8","volume":"10","author":"Y Fu","year":"2011","unstructured":"Fu Y, Sun Y-L, Ma X-X, et al. Necessity and indications of invasive treatment for Budd-Chiari syndrome. Hepatobiliary Pancreat Dis Int. 2011;10(3):254\u201360.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2945_CR4","doi-asserted-by":"crossref","unstructured":"Leoni FG, Magnano San Lio P, de Molo C, et al. Budd\u2013Chiari syndrome (BCS): a challenging diagnosis not to be overlooked\u2014single center report and pictorial essay. J Ultrasound. 2022.","DOI":"10.1007\/s40477-022-00723-x"},{"issue":"3","key":"2945_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cld.2020.04.012","volume":"24","author":"LYK Haque","year":"2020","unstructured":"Haque LYK, Lim JK. Budd-Chiari Syndrome. Clin Liver Dis. 2020;24(3):453\u201381.","journal-title":"Clin Liver Dis"},{"key":"2945_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-103-3-329","volume":"103","author":"D Valla","year":"1985","unstructured":"Valla D, Casadevall N, Lacombe C, Varet B, Goldwasser E, Franco D, Maillard JN, Pariente EA, Leporrier M, Rueff B. Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med. 1985;103:329\u201334.","journal-title":"Ann Intern Med"},{"issue":"22","key":"2945_CR7","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1111\/jcmm.17911","volume":"27","author":"L Zhang","year":"2023","unstructured":"Zhang L, Feng B, Zhou Z, et al. Extracellular vesicles-transmitted long non-coding RNA MTUS2-5 promotes proliferation and vascularization of human vascular endothelial cells in patients with Budd-Chiari syndrome. J Cell Mol Med. 2023;27(22):3431\u201342.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"2945_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nrendo.2014.60","volume":"10","author":"F Kuipers","year":"2014","unstructured":"Kuipers F, Bloks VW, Groen AK. Beyond intestinal soap\u2014bile acids in metabolic control. Nat Rev Endocrinol. 2014;10(8):488\u201398.","journal-title":"Nat Rev Endocrinol"},{"key":"2945_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejphar.2016.06.007","volume":"786","author":"X Wang","year":"2016","unstructured":"Wang X, Zhang Z, He X, et al. Taurochenodeoxycholic acid induces NR8383 cells apoptosis via PKC\/JNK-dependent pathway. Eur J Pharmacol. 2016;786:109\u201315.","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"2945_CR10","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.intimp.2011.09.011","volume":"11","author":"M Liu","year":"2011","unstructured":"Liu M, Mao W, Guan H, et al. Effects of taurochenodeoxycholic acid on adjuvant arthritis in rats. Int Immunopharmacol. 2011;11(12):2150\u20138.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"2945_CR11","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.numecd.2024.02.001","volume":"34","author":"W Huang","year":"2024","unstructured":"Huang W, Zhang M, Qiu Q, et al. Metabolomics of human umbilical vein endothelial cell-based analysis of the relationship between hyperuricemia and dyslipidemia. Nutr Metab Cardiovasc Dis. 2024;34(6):1528\u201337.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2945_CR12","doi-asserted-by":"crossref","unstructured":"Siess W, Zangl KJ, Essler M, Bauer M, Brandl R, Corrinth C, Bittman R, Tigyi G, Aepfelbacher M. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci U S A, 1999.","DOI":"10.1073\/pnas.96.12.6931"},{"key":"2945_CR13","doi-asserted-by":"crossref","unstructured":"Plastira I, Bernhart E, Joshi L, et al. MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia. J Neuroinflamm. 2020; 17(1).","DOI":"10.1186\/s12974-020-01809-1"},{"key":"2945_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01261-7","author":"JM Hong","year":"2023","unstructured":"Hong JM, Lee J-W, Seen D-S, et al. LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration. Cell Commun Signal. 2023. https:\/\/doi.org\/10.1186\/s12964-023-01261-7.","journal-title":"Cell Commun Signal"},{"key":"2945_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00367-5","author":"LHM Geraldo","year":"2021","unstructured":"Geraldo LHM, Spohr TCLDS, Amaral RFD, et al. Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies. Signal Transduct Target Ther. 2021. https:\/\/doi.org\/10.1038\/s41392-020-00367-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2945_CR16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/stem.1882","volume":"33","author":"JM Ryu","year":"2015","unstructured":"Ryu JM, Han HJ. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1\/3-dependent PKC\/GSK3\u03b2\/\u03b2-catenin and PKC\/Rho GTPase pathways. Stem Cells. 2015;33(3):819\u201332.","journal-title":"Stem Cells"},{"issue":"35","key":"2945_CR17","doi-asserted-by":"publisher","first-page":"14391","DOI":"10.1074\/jbc.M117.781807","volume":"292","author":"D An","year":"2017","unstructured":"An D, Hao F, Zhang F, et al. CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation. J Biol Chem. 2017;292(35):14391\u2013400.","journal-title":"J Biol Chem"},{"key":"2945_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101152","author":"F Hao","year":"2021","unstructured":"Hao F, Liu Q, Zhang F, et al. LPA1-mediated PKD2 activation promotes LPA-induced tissue factor expression via the p38\u03b1 and JNK2 MAPK pathways in smooth muscle cells. J Biol Chem. 2021. https:\/\/doi.org\/10.1016\/j.jbc.2021.101152.","journal-title":"J Biol Chem"},{"issue":"12","key":"2945_CR19","first-page":"4646","volume":"7","author":"X Dang","year":"2014","unstructured":"Dang X, Li L, Xu P. Research status of Budd-Chiari syndrome in China. Int J Clin Exp Med. 2014;7(12):4646\u201352.","journal-title":"Int J Clin Exp Med"},{"issue":"9","key":"2945_CR20","first-page":"611","volume":"93","author":"G Aguirrebarrena","year":"2001","unstructured":"Aguirrebarrena G, Pulcinelli S, Giovannoni AG, et al. Celiac disease and Budd-Chiari syndrome: infrequent association. Rev Esp Enferm Dig. 2001;93(9):611\u20132.","journal-title":"Rev Esp Enferm Dig"},{"key":"2945_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2021.106617","volume":"108","author":"Y Yousefi","year":"2021","unstructured":"Yousefi Y, Mortezania Z, Abolmolouki M, et al. A novel form of anti-angiogenic molecular antibody drug induces apoptosis in myeloma cells after cultivation upon endothelial feeder cells. Leuk Res. 2021;108: 106617.","journal-title":"Leuk Res"},{"key":"2945_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbi.2021.09.021","volume":"99","author":"F Huang","year":"2022","unstructured":"Huang F, Pariante CM, Borsini A. From dried bear bile to molecular investigation: a systematic review of the effect of bile acids on cell apoptosis, oxidative stress and inflammation in the brain, across pre-clinical models of neurological, neurodegenerative and neuropsychiatric disorders. Brain Behav Immun. 2022;99:132\u201346.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"2945_CR23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/jnc.15727","volume":"164","author":"A Smaling","year":"2023","unstructured":"Smaling A, ROMERO-RAM\u00edREZ L, Mey J. Is TGR5 a therapeutic target for the treatment of spinal cord injury? J Neurochem. 2023;164(4):454\u201367.","journal-title":"J Neurochem"},{"issue":"10","key":"2945_CR24","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1021\/bi026979d","volume":"42","author":"CM Rodrigues","year":"2003","unstructured":"Rodrigues CM, SOL\u00e1 S, Sharpe JC, et al. Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome C release in isolated mitochondria. Biochemistry. 2003;42(10):3070\u201380.","journal-title":"Biochemistry"},{"key":"2945_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101144","volume":"22","author":"YM Yoon","year":"2019","unstructured":"Yoon YM, Kim S, Han YS, et al. TUDCA-treated chronic kidney disease-derived hMSCs improve therapeutic efficacy in ischemic disease via PrP(C). Redox Biol. 2019;22: 101144.","journal-title":"Redox Biol"},{"issue":"3","key":"2945_CR26","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2741\/4148","volume":"18","author":"Y Chen","year":"2013","unstructured":"Chen Y, Ramakrishnan DP, Ren B. Regulation of angiogenesis by phospholipid lysophosphatidic acid. Front Biosci (Landmark edition). 2013;18(3):852\u201361.","journal-title":"Front Biosci (Landmark edition)"},{"key":"2945_CR27","doi-asserted-by":"crossref","unstructured":"Lee JH, Kim D, Oh YS, et al. Lysophosphatidic acid signaling in diabetic nephropathy. Int J Mol Sci. 2019; 20(11).","DOI":"10.3390\/ijms20112850"},{"key":"2945_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910777","author":"D Kim","year":"2021","unstructured":"Kim D, Kim HJ, Baek JO, et al. Lysophosphatidic acid mediates imiquimod-induced psoriasis-like symptoms by promoting keratinocyte proliferation through LPAR1\/ROCK2\/PI3K\/AKT signaling pathway. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms221910777.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2945_CR29","doi-asserted-by":"publisher","first-page":"E189","DOI":"10.1097\/BSD.0000000000000048","volume":"30","author":"K Zhang","year":"2017","unstructured":"Zhang K, Sun W, Liu XY, et al. Hypertrophy and fibrosis of the Ligamentum flavum in lumbar spinal stenosis is associated with increased expression of LPA and LPAR1. Clin Spine Surg A Spine Publ. 2017;30(3):E189\u201391.","journal-title":"Clin Spine Surg A Spine Publ"},{"issue":"1","key":"2945_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2011.04.084","volume":"409","author":"L Gan","year":"2011","unstructured":"Gan L, Xue JX, Li X, et al. Blockade of lysophosphatidic acid receptors LPAR1\/3 ameliorates lung fibrosis induced by irradiation. Biochem Biophys Res Commun. 2011;409(1):7\u201313.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02945-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02945-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02945-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:21:16Z","timestamp":1759234876000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02945-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2945"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02945-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6817130\/v1","asserted-by":"object"}]},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to particiate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"918"}}